论文部分内容阅读
近年来随着围产医学的迅速发展及新生儿重症监护病房(NICU)的逐步建立,新生儿缺氧缺血性脑病(HIE)的存活率明显升高,但存活者永久性神经系统后遗症的发生率仍较高。如何改善预后,提高儿童生存质量,是目前备受重视的研究课题。我科自1996年以来对重度HIE及部分中度HIE患儿进行新生儿期后多疗程脑活素配合复方丹参注射液治疗,疗效满意,现报告如下。 1 临床资料 1.1 一般资料:所有住院的HIE患儿中符合下列
In recent years, with the rapid development of perinatal medicine and the establishment of neonatal intensive care unit (NICU), the survival rate of neonatal hypoxic-ischemic encephalopathy (HIE) increased significantly, but the permanent neurological sequelae of survivors The incidence is still high. How to improve the prognosis and improve children’s quality of life are the research topics that have received much attention. Since 1996, our department of severe HIE and some children with moderate HIE neonatal post-neonatal multiple doses of cerebrolysin with compound Danshen injection, the effect is satisfactory, are as follows. 1 Clinical data 1.1 General information: All hospitalized children with HIE meet the following